Financials
- Market Capitalization 350.24 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.61
ratio cours/chiffre d'affaires
54.94
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3185 | IRD Opus Genetics, Inc. - Common Stock | 4.32 USD | +12.79% | +9.64% | +16.13% | +16.13% | 359.41 M USD | ||
| 3186 | PALI Palisade Bio, Inc. - Common Stock | 1.98 USD | +1.02% | -6.60% | +4.21% | +16.47% | 345.06 M USD | ||
| 3196 | STRO Sutro Biopharma, Inc. - Common Stock | 20.34 USD | -2.31% | -4.10% | -15.14% | +16.96% | 337.26 M USD | ||
| 3205 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.67 USD | -0.81% | -5.17% | +2.23% | +69.12% | 333.92 M USD |